Heme/Onc Flashcards

(48 cards)

0
Q

Milan Criteria for OLT in HCC

A

One lesion <3cm No extra hepatic manifestations No vascular invasion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

HNPCC criteria

A

3-2-1 rule: 3 relatives with HNPCC assoc cancer 2 generations 1 person died before 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

This hormone always indicates a non-seminomatous component in a testicular tumor

A

alpha-fetoprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Follow up surveillance for colon cancer

A

(1) CT chest/abd/pelvis q1year x 3 years (2) CEA q3-6 months for the first 2 years then q6months for the next 3 years (3) Colonoscopy 1 year, then 3 years later, then q5years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CD55 and CD59 on flow cytometry

A

Paroxysmal nocturnal hemoglobinuria (PNH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ADAMTS13

A

TTP-HUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anti-PF4 antibodies

A

HIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

JAK 2 Mutation

A
  • Essential Thrombocythema - Polycythemia Vera - Primary Myelofibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

9,22 translocation (Philadelphia Chromosome)

A

Chronic myeloid leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How to distinguish alpha-thalassemia trait vs. beta-thalassemia trait in microcytic anemia

A

Hemoglobin electrophoresis - normal in alpha-thal trait; elevated A2 and fetal hemoglobin in beta-thal trait

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment of polycythemia vera

A
  • Low-dose aspirin and phlebotomy - Hydroxyurea if: >60 y/o or prior thrombotic event
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of chronic myeloid leukemia (CML)

A

Imatinib - bcr-abl inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Form of AML associated with DIC

A

Acute promyelocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of acute promyelocytic leukemia (APL)

A

All-trans-retinoic acid + arsenic trioxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(15;17) gene translocation

A

Acute promyelocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of 5q- syndrome

A

Lenalidomide (5q- syndrome is a sub-type of MDS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Smudge cells

A

Chronic lymphocytic leukemia (CLL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antibodies to HPA-1a

A

Posttransfusion purpura

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Leukoreduction of PRBCs

A

Decreases the incidence of febrile nonhemolytic transfusion reactions, cytomegalovirus transmission, and alloimmunization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Factor(s) that prolong only PTT

21
Q

Factor(s) that prolong only PT

22
Q

Treatment of acquired Factor VIII inhibitors

A

Recombinant Factor VIIa.

23
Q

Blood tests to confirm suspected B12 deficiency

A

Elevated homocysteine and methylmalonic acid

24
Q

Periorbital purpura and macroglossia

A

AL amyloidosis

25
Treatment of high-risk MDS
Azacitidine
26
Number of blasts in blood or bone marrow to dx AML
\>20%
27
MDS transforms into...
AML
28
Acute hemolytic transfusion reaction
ABO incompatibility
29
Delayed hemolytic transfusion reaction
Alloantibody that causes rapid clearance of RBCs 1-3 days after transfusion
30
Febrile non-hemolytic transfusion reaction
Donor leukocyte cytokines OR Recipient alloantibodies against donor leukocytes Tx: Leukocyte reduction of further transfusions
31
Transfusion-associated acute lung injury
Donor anti-leukocyte antibodies --\> Leukocytes aggregate in pulmonary capillary bed
32
Transfusion-associated GVHD
Donor lymphocytes engraft in immunocompromised recipient Tx: Gamma-irradiation of blood products
33
Conditions treated with plasmapheresis (plasma exchange)
- Guillain-Barre - Myasthenia gravis - TTP-HUS - Waldenström macroglobulinemia-related hyperviscosity syndrome - Transverse myelitis
34
Bite cells
G6PD
35
INR reversal in life-threatening bleeding
IV vitamin K + Prothrombin complex concentrate (PCC)
36
Overexpression of cyclin D1 and a t(11:14) translocation
Mantle cell lymphoma
37
EGFR inhibitors
Erlotinib (Tarceva) and gefitinib
38
Type of chemo given in testicular cancer
Cisplatin-based
39
Treatment of hairy cell leukemia
Cladribine
40
Chemo used in colon cancer
FOLFOX (5-FU, leucovorin, oxaliplatin)
41
Chemo for CLL
Fludarabine + Rituximab
42
Chemo for Hodgkin lymphoma
ABVD = adriamycin (doxorubicin), bleomycin, vincristine, dacarbazine
43
β2-Microglobuin
Prognostication in chronic lymphocytic leukemia (CLL)
44
Chemo for AML
"7 and 3" cytarabine + anthracycline
45
Bite Cells G6PD deficiency
46
Target cells Alpha- and beta-thalassemia
47
Spherocytes Hereditary spherocytosis; warm autoimmune hemolytic anemia
48
Cold agglutinin disease Erythrocytes are clumped, leading to falsely elevated MCV. Associated with IgM antibodies to erythrocyte antigens.